Does Finerenone’s Efficacy Diminish if Initiated Late in Heart Failure?

MedPage Today) — The benefit-risk profile of finerenone (Kerendia) for heart failure and mildly reduced or preserved ejection fraction (HFmrEF, HFpEF) was arguably unchanged with delayed initiation, according to the FINEARTS-HF trial.
An analysis…